| In Vitro |
MEK-IN-5 (compound 18h) shows anti-proliferation activities for different tumor cells and low toxicity for normal cells[1]. MEK-IN-5 (0.1, 1, 10 µM; 1, 2, 4, 6 h) decreases the expression level of pMEK and pERK in a dose-dependent and time-dependent manner[1]. MEK-IN-5 (1, 10 µM; 24 h) induces apoptosis in MDA-MB-231 cells[1]. MEK-IN-5 (100 µM; 2h) significantly induce NO release in HCT116 cells[1]. Cell Proliferation Assay[1] Cell Line: MDA-MB-231, HCT116, A549, Vero, HL7702 cells Concentration: Incubation Time: Result: Showed anti-proliferation activities in MDA-MB-231, HCT116, A549, Vero, HL7702 cells with IC50s of 0.034, 0.64, 1.35, 21.07, 5.62 µM, respectively. Western Blot Analysis[1] Cell Line: MDA-MB-231 cells Concentration: 0.1, 1, 10 µM Incubation Time: 1, 2, 4, 6 h Result: Decreased the expression level of pMEK and pERK in a dose-dependent and time-dependent manner. Apoptosis Analysis[1] Cell Line: MDA-MB-231 cells Concentration: 1, 10 µM Incubation Time: 24 h Result: Induced apoptosis in MDA-MB-231 cells.
|
